Inercia Cero: Corazón, Riñón y Metabolismo
Where it charts
Today’s combined position on our country charts.
Ranking history
About the show
Latest episodes
-
ZUPREME 1: Petrelintida (analogo de amilina) en obesidad (Lancet 2026)
October 8, 2026 · 23 minInstagram: @dr.gilbertogarciabernal X: @GilbertoG_MD Petrelintide, a human amylin analogue for the treatment of obesity (ZUPREME 1): a randomised, double-blind, placebo-controlled, phase 2 trial (Lancet Diabetes Endocrinol, 2026)Este…
-
ACHIEVE-4: Orforglipron vs Insulina Glargina en DT2 (Lancet 2026)
October 7, 2026 · 21 minInstagram: @dr.gilbertogarciabernal X: @GilbertoG_MD Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised…
-
REMODEL: Semaglutida en ERC en DT2 (Nature 2026)
October 6, 2026 · 14 minInstagram: @dr.gilbertogarciabernal X: @GilbertoG_MD Effects of semaglutide on kidney disease in type 2 diabetes: a randomized placebo-controlled trial (Nat. Med., 2026)Este ensayo clínico aleatorizado evaluó los efectos de la…
-
Prevencion de Falla Cardiaca (ESC 2026)
October 5, 2026 · 24 minPrevention of heart failure (Eur Heart J, 2026)Este comunicado científico de la Sociedad Europea de Cardiología (ESC) proporciona un marco integral y actualizado para la prevención primaria de la insuficiencia cardíaca, enfocándose en…
-
Entrenamiento de Fuerza y Diabetes tipo 2 (2026)
October 4, 2026 · 26 minInstagram: @dr.gilbertogarciabernal X: @GilbertoG_MD Resistance Training and Diabetes Mellitus Type 2: An Umbrella Review of Systematic Reviews and Meta-analyses on Glycemic and Cardiometabolic Outcomes (Metabolism, 2026)Esta revisión…
-
Consenso ADA & EASD 2026: Manejo de la Diabetes tipo 2
October 3, 2026 · 15 minManagement of type 2 diabetes, 2026. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (Diabetologia, 2026)Este informe de consenso actualizado amplía el enfoque del…
-
TRIUMPH 1 y 2: Retatrutida (NEJM, Lancet 2026)
October 2, 2026 · 22 minInstagram: @dr.gilbertogarciabernal X: @GilbertoG_MD Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial (Lancet, 2026)Este ensayo clínico de…
-
AR GLP-1: Abordaje nutricional, funcional y psicológico (Lancet 2026)
October 1, 2026 · 28 minInstagram: @dr.gilbertogarciabernal X: @GilbertoG_MD Nutritional, functional, and psychological considerations for incretin-based therapies in adults—an EASO, EFAD, and ECPO Consensus Statement (Lancet Diabetes Endocrinol, 2026) Este…